Page last updated: 2024-08-21

isoxazoles and 3,4-methylenedioxyamphetamine

isoxazoles has been researched along with 3,4-methylenedioxyamphetamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, F; Jones, DC; Lau, SS; Monks, TJ	1

Other Studies

1 other study(ies) available for isoxazoles and 3,4-methylenedioxyamphetamine

Article	Year
Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase. Chemical research in toxicology, 2001, Volume: 14, Issue:7 Topics: 3,4-Methylenedioxyamphetamine; Administration, Cutaneous; Animals; Brain; Endothelium; Enzyme Inhibitors; gamma-Glutamyltransferase; Humans; Isoxazoles; Male; Models, Molecular; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents	2001

Article

Year

Serotonergic neurotoxicity of 3,4-(+/-)-methylenedioxyamphetamine and 3,4-(+/-)-methylendioxymethamphetamine (ecstasy) is potentiated by inhibition of gamma-glutamyl transpeptidase.

Chemical research in toxicology, 2001, Volume: 14, Issue:7

Topics: 3,4-Methylenedioxyamphetamine; Administration, Cutaneous; Animals; Brain; Endothelium; Enzyme Inhibitors; gamma-Glutamyltransferase; Humans; Isoxazoles; Male; Models, Molecular; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents

2001